Results 61 to 70 of about 394,432 (188)
ABSTRACT Myotonic dystrophy type 1 (DM1) is a progressive muscular disorder caused by the expansion of CTG repeats in the 3′ UTR of the DMPK gene. Although the pathogenic mechanisms remain unclear, recent evidence suggests that activation of innate immune responses may contribute to disease progression. In this study, we examined the ultrastructure and
Renata Del Carratore +8 more
wiley +1 more source
We have identified 4 pathogenic/likely pathogenic changes and 2 variants of uncertain significance, 3 of which were novel. The identification of disease‐causing variants in the CRYAA, MYH9, RP2, and CLNC1 genes allowed us to establish an accurate genetic diagnosis of inherited cataract and to describe overlapping clinical phenotypes.
Kristiyana Vitanova +10 more
wiley +1 more source
Anesthesia for a Patient with Myotonic Dystrophy
Myotonic dystrophy is the most common myotonic syndrome causing abnormalities of the skeletal and smooth muscles as well as problems related to the cardiac, gastrointestinal and endocrine systems. In affected people, reduced functional residual capacity,
Dilek Kalaycı +6 more
core +1 more source
Model Organisms in the Fight against Muscular Dystrophy: Lessons from Drosophila and Zebrafish
Muscular dystrophies (MD) are a heterogeneous group of genetic disorders that cause muscle weakness, abnormal contractions and muscle wasting, often leading to premature death.
Emilie Plantié +3 more
doaj +1 more source
Two loci for the dystrophic myotonias are known and described as DM1 and DM2. At both loci inheritance is autosomal dominant, with DM1 associated with a CTG trinucleotide expansion on chromosome 19q13.3 and DM2 with a CCTG tetranucleotide expansion at 3q21. DM2 is not associated with a CDM phenotype, (although neonatal club foot has been once reported [
openaire +1 more source
A 6‐month‐old male Jack Russell Terrier presenting with muscle wasting and lethargy was diagnosed with Duchenne‐like muscular dystrophy based on clinical, electromyographic, histopathological, and immunohistochemical evidence of dystrophin deficiency. Whole genome sequencing identified a novel 25.5 kb deletion encompassing exons 8 and 9 of the DMD gene,
Emilie Royaux +4 more
wiley +1 more source
Malignant Hyperthermia in Sweden: Clinical Presentations and Genetic Findings
ABSTRACT Introduction Malignant hyperthermia (MH) is a pharmacogenetic, hypermetabolic and potentially lethal reaction to potent volatile anaesthetics and the muscle relaxant succinylcholine. To improve the understanding of MH, the aim of this retrospective study was to describe the Swedish cohort with respect to clinical manifestations, demographics ...
Anna Hellblom +2 more
wiley +1 more source
Increasing evidences indicate that in Myotonic Dystrophy type 1 (DM1 or Steinert disease), an autosomal dominant multisystem disorder caused by a (CTG)n expansion in DMPK gene on chromosome 19q13.
Costanza Simoncini +6 more
doaj +1 more source
Advances in genomic, proteomic, and transcriptomic technologies are transforming the diagnosis of genetic myopathies. When integrated with traditional muscle pathology, multi‐omics approaches improve diagnostic yield, clarify disease mechanisms, and support more precise, mechanism‐based therapeutic strategies for patients with neuromuscular disorders ...
Ludmila Alem +2 more
wiley +1 more source

